Testimonials
Left Column Title:
Testimonials
Left Column Content:
Brad Curtis, Senior Research Scientist (Lilly)
"I have had the good fortune of working with the Archimedes team recently on a project related to understanding some early phase data, and designing a clinical trial in the therapeutic area of diabetes.
From the beginning, the Archimedes team became an extension of the team here at Lilly; they quickly came up to speed with the requirements of the research, helped us identify the key gaps, and more importantly came up with creative (and scientifically sound) solutions to those issues.
They were very responsive and flexible - as the needs of the project changed somewhat after the first stage - while still managing to deliver the project with high quality on time and on budget. I couldn't be happier - this is a great company to work with".
From the beginning, the Archimedes team became an extension of the team here at Lilly; they quickly came up to speed with the requirements of the research, helped us identify the key gaps, and more importantly came up with creative (and scientifically sound) solutions to those issues.
They were very responsive and flexible - as the needs of the project changed somewhat after the first stage - while still managing to deliver the project with high quality on time and on budget. I couldn't be happier - this is a great company to work with".
Richard Kahn, Former CSMO (ADA)
"The proven accuracy of the Archimedes Model in simulating clinical trials makes it an exceptional tool for comparing the effectiveness of interventions."
Risa Lavizzo-Mourey, CEO (RWJF)
“With the development of ARCHeS, we are ushering in a new era in medical decision-making that may transform the quality and efficiency of health care for all Americans"
Right Column Content:
Richard Wenstrup, CMO (Myriad Genetic)
"The return on our investment for the work done by Archimedes was exceptional. Their expertise, spanning a range from the finest of scientific details all the way up to generating influential results and a national spotlight will continue to benefit Myriad and the patients we serve for some time to come."
Samir Patel, MD (Kaiser Permanente)
“IndiGO is really changing the dynamics and the conversations in the exam room. For the first time, we have a real time tool which helps the physician and the patient look at information together and collaboratively decide among the various options.”
Marc Roberts, Professor (U of Pittsburgh)
"I’ve spent probably 25 years of my academic life trying to understand how to make these kinds of decision models be more clinically realistic. David is so far ahead of anyone else in the field — it really is amazing.”
James Dudl, Clinical Diabetes Lead (CMI)
"Archimedes was a decisive factor in changing our care from a simple initiative without significant savings, into a program that now saves lives, heart attacks and strokes and has more than paid for itself."
